| Literature DB >> 24579048 |
Diana Nordquist1, Thomas M Halaszynski1.
Abstract
Background. Elderly patients have unique age-related comorbidities that may lead to an increase in postoperative complications involving neurological, pulmonary, cardiac, and endocrine systems. There has been an increase in the number of elderly patients undergoing surgery as this portion of the population is increasing in numbers. Despite advances in perioperative anesthesia and analgesia along with improved delivery systems, monotherapy with opioids continues to be the mainstay for treatment of postop pain. Reliance on only opioids can oftentimes lead to inadequate pain control or increase in the incidence of adverse events. Multimodal analgesia incorporating regional anesthesia is a promising alternative that may reduce needs for high doses and dependence on opioids along with any potential associated adverse effects. Methods. The following databases were searched for relevant published trials: Cochrane Central Register of Controlled Trials and PubMed. Textbooks and meeting supplements were also utilized. The authors assessed trial quality and extracted data. Conclusions. Multimodal drug therapy and perioperative regional techniques can be very effective to perioperative pain management in the elderly. Regional anesthesia as part of multimodal perioperative treatment can often reduce postoperative neurological, pulmonary, cardiac, and endocrine complications. Regional anesthesia/analgesia has not been proven to improve long-term morbidity but does benefit immediate postoperative pain control. In addition, multimodal drug therapy utilizes a variety of nonopioid analgesic medications in order to minimize dosages and adverse effects from opioids while maximizing analgesic effect and benefit.Entities:
Year: 2014 PMID: 24579048 PMCID: PMC3918371 DOI: 10.1155/2014/902174
Source DB: PubMed Journal: Pain Res Treat ISSN: 2090-1542
Regional anesthesia.
| Types of upper extremity blockade | Interscalene |
| Supraclavicular | |
| Infraclavicular | |
| Axillary | |
| Intravenous regional | |
|
| |
| Types of lower extremity blockade | Lumbar plexus |
| Sciatic | |
| Femoral | |
| Lateral femoral cutaneous | |
| Obturator | |
| Popliteal and saphenous | |
| Ankle | |
|
| |
| Types of head and neck blockade | Cervical plexus |
| Stellate | |
| Occipital | |
| Maxillary | |
| Mandible | |
| Retrobulbar | |
|
| |
| Types of truncal blockade | Intercostal |
| Interpleural | |
| Paravertebral | |
| Transversus abdominis plane | |
|
| |
| Neuraxial | Spinal |
| Epidural | |
| Caudal | |
| Benefits of regional anesthesia | |
| (i) Improve acute perioperative pain management | |
| (ii) Reduced opioid use along with reduced incidence of adverse events | |
| (iii) Can obtain skeletal muscle relaxation, thus limiting need and risks of IV muscle relaxants | |
| (iv) Option to maintain patient consciousness | |
| (v) Continued presence of protective upper airway reflexes | |
| (vi) An isolated regional modality will have minimal effect on pulmonary or cardiac disease |
| Definitions of altered mental status | |
|---|---|
| Condition | Definition |
| Postoperative cognitive dysfunction (POCD) | Persistent deterioration of cognitive performance after surgery most often resolves within 3 months but can last longer |
|
| |
| Delirium | Decline in mental status, reduced awareness, cognitive and psychomotor dysfunction, disorientation, and memory impairment |
|
| |
| Altered pharmacodynamics | Increased effect of drug on the body; for example, exaggerated respiratory and cardiovascular depression from narcotics |
|
| |
| Stroke | Decreased blood supply to the brain due to ischemia or hemorrhage. There is an increased risk in the elderly, because of autonomic dysfunction, decreased baroreceptor sensitivity, and loss of vascular elasticity |
|
| |
| Hyperalgesia | Paradoxical increase in pain intensity, new pain complaints, and altered pain characteristics while receiving treatment with opioids |
| Changes in the aging central nervous system | |
| (i) Decreased synaptic transmission | |
| (ii) Diffuse slowing on EEG | |
| (iii) Decreased oxygen and glucose consumption | |
| (iv) Loss of neuronal substance | |
| (v) Decreased production of neurotransmitters | |
| (vi) Decrease in cytoplasmic protein synthesis | |
| (vii) Decreased myelin glycoproteins |
Cardiovascular system changes in the elderly.
| (i) Reduced exercise tolerance | |
| (ii) Loss of vascular elasticity (e.g., LVH and hypertension) | |
| (iii) Chronic blood pressure elevation and decreased baroreceptor sensitivity | |
| (iv) Increase in coronary arteriosclerosis | |
| (v) Valvular heart disease |
Pulmonary system changes in the elderly.
| (i) Decreased chest wall compliance due to changes in muscle and chest wall joints | |
| (ii) Increased lung compliance due to loss in parenchymal elasticity | |
| (iii) Decreased lung parenchymal surface area leading to decreased efficiency of alveolar gas exchange due to increase in dead space and shunt | |
| (iv) Decrease FEV1, decreased TV, and increased RR | |
| (v) Hypotonia of pharyngeal muscles leading to upper airway obstruction | |
| (vii) Decreased responsiveness to hypercapnia and hypoxia | |
| (viii) Increased work of breathing |
ASRA guidelines for RA in the patient receiving anticoagulation therapy.
| Anticoagulation | Dosage | Recommendations |
|---|---|---|
| Unfractionated heparin | SC BID | No contraindications |
| SC TID | No recommendations—unknown risk | |
| IV loading dose | Delay administration >1 hour after needle placement or catheter removal | |
| Remove catheter 2–4 hours after last dose | ||
| LMWH | SC daily | Needle placement or catheter removal 10–12 hours after last dose |
| Delay dosing 2 hours after removal of catheter | ||
| SC BID | Needle placement or catheter removal 24 hours after last dose | |
| Delay dosing 2 hours after removal of catheter | ||
| Warfarin | Stop 4-5 days prior to neuraxial technique, INR < 1.5 prior to needle placement or catheter removal | |
| NSAID | No contraindications | |
|
| ||
| GPIIB/IIIA antagonists | ||
| Ticlopidine | Delay 14 days | |
| Clopidogrel | Delay 7 days | |
| Herbal therapy | No contraindications when used independently | |